Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureYajing Bai, Yinghong Bai, Shiwei Liu
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Panvascular medicine: an emerging discipline focusing on atherosclerotic diseases
10.1093/eurheartj/ehac448 · 2022
Diabetic retinopathy
10.1016/s0140-6736(09)62124-3 · 2010
Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics
10.1038/s41380-023-02066-3 · 2023
Oxidative stress and diabetic complications
10.1161/circresaha.110.223545 · 2010
Diabetic peripheral neuropathy: current perspective and future directions
10.1016/j.phrs.2013.12.005 · 2014
The Role of Aldose Reductase in Beta-Amyloid-Induced Microglia Activation
10.3390/ijms232315088 · 2022
Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells
10.1016/j.cbi.2014.10.007 · 2015
Effects of sorbinil on glomerular structure and function in long-term- diabetic rats
10.2337/diab.38.7.839 · 1989
Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
10.1038/s41588-020-0615-4 · 2020
datacite
Confidence 0%
Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cel l apoptosis and diabetic retinopathy
10.1038/nm.2052 · 2009
METTL3-mediated N6-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication
10.7150/thno.63441 · 2022
Targeting single-cell multiomics-identified vascular impairment: Panax notoginseng extracellular vesicles-loaded adhesive QBK-2/EVs promotes angiogenesis in diabetic wound healing
2026
Protein glycation: a firm link to endothelial cell dysfunction
10.1161/01.res.0000137876.28454.64 · 2004
Free Radicals in Health and Disease
10.1002/mco2.70396 · 2025
Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy
10.1038/s41419-021-03750-4 · 2021
Potential mechanisms of metabolic reprogramming induced by ischemia-reperfusion injury in diabetic myocardium
10.1111/1753-0407.70018 · 2024
Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease
10.1042/cs20180702 · 2018
Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism
10.1016/j.cmet.2020.10.019 · 2020
Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier
10.1093/eurheartj/ehaa207 · 2020
Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors
10.1111/j.1365-2362.2011.02475.x · 2011
The Dual Role of Interleukin-6 in the Pathophysiology of Skeletal Muscle: Mechanisms, Challenges, and Therapeutic Prospects
10.3390/ph19060868 · 2026
Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes
10.1001/jama.2013.276305 · 2013
Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes
10.2337/db19-0145 · 2019
Vascular endothelial cells synthesize nitric oxide from L-arginine
10.1038/333664a0 · 1988
Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure
10.1161/circulationaha.120.049606 · 2021
A Ternary Synergistic eNOS Gene Delivery System Based on Calcium Ion and L-Arginine for Accelerating Angiogenesis by Maximizing NO Production
10.2147/ijn.s363168 · 2022
Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels
10.1111/joim.12461 · 2016
Serine and glycine metabolism in cancer
10.1016/j.tibs.2014.02.004 · 2014
Compartmentalization of Mammalian folate-mediated one-carbon metabolism
10.1146/annurev.nutr.012809.104810 · 2010
One-Carbon Metabolism Supports S-Adenosylmethionine and Histone Methylation to Drive Inflammatory Macrophages
10.1016/j.molcel.2019.06.039 · 2019
Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications
10.3390/ijms26073016 · 2025
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells
10.1172/jci18127 · 2003
Endogenous asymmetric dimethylarginine accumulation contributes to the suppression of myocardial mitochondrial biogenesis in type 2 diabetic rats
10.1186/s12986-020-00486-4 · 2020
Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis
10.1016/j.redox.2018.02.013 · 2018
ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria i n VEGF signaling and angiogenesis
10.1152/ajpcell.00346.2016 · 2017
Network of cell death in myocardial ischemia-reperfusion injury: mechanisms and targeted therapeutic strategies
10.1016/j.bcp.2026.117999 · 2026
Endoplasmic reticulum stress and unfolded protein response: Roles in skeletal muscle atrophy
10.1016/j.bcp.2025.116799 · 2025
AMPK/SIRT1/PGC-1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy
10.1111/cns.70657 · 2025
Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture
10.2337/dbi20-0030 · 2021
Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios
10.1016/j.metabol.2020.154308 · 2020
Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy
10.1038/s41467-022-29060-7 · doi-reference
Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
10.1038/s41467-019-09735-4 · doi-reference
Management of inflammation in cardiovascular diseases
10.1016/j.phrs.2021.105912 · doi-reference
Mitochondria, endothelial cell function, and vascular diseases
10.3389/fphys.2014.00175 · doi-reference
Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases
10.1152/ajpheart.00201.2016 · doi-reference
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIOR ITY): a prospective observational study and embedded randomised placebo-controlled trial
10.1016/s2213-8587(20)30026-7 · doi-reference
Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model
10.7150/thno.16803 · doi-reference
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
10.1016/s0140-6736(19)30772-x · doi-reference
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: result s from a Phase 2 randomized controlled clinical trial
10.1093/ndt/gfx377 · doi-reference
Nuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation
10.1016/j.bbadis.2021.166238 · doi-reference
The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes
10.2337/dc20-2684 · doi-reference
Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
10.1111/dom.12608 · doi-reference
Effects on the incidence of cardiovascular events of the addition of p ioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
10.1016/s2213-8587(17)30317-0 · doi-reference
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker
10.1161/hc3801.097806 · doi-reference
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke
10.1186/s12974-019-1638-6 · doi-reference
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
10.1056/nejmoa1901118 · doi-reference
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
10.1056/nejmoa1603827 · doi-reference
A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice
10.1016/j.kint.2018.05.002 · doi-reference
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
10.1161/circulationaha.118.037418 · doi-reference
Dapagliflozin in Patients with Chronic Kidney Disease
10.1056/nejmoa2024816 · doi-reference
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
10.1056/nejmoa1811744 · doi-reference
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
10.1056/nejmoa1812389 · doi-reference
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
10.1056/nejmoa1611925 · doi-reference
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® tri al
10.1093/eurheartj/ehv728 · doi-reference
Specific PKC βII inhibitor: one stone two birds in the treatment of di abetic foot ulcers
10.1042/bsr20171459 · doi-reference
10-year follow-up of intensive glucose control in type 2 diabetes
10.1056/nejmoa0806470 · doi-reference
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
10.1093/eurheartj/ehaa898 · doi-reference
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
10.1056/nejmoa1504720 · doi-reference
Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice
10.1186/s12933-016-0408-3 · doi-reference
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes
10.1212/wnl.0000000000004586 · doi-reference
Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study
10.2337/dc20-0892 · doi-reference
Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes
10.1016/j.kint.2018.09.019 · doi-reference
Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy
10.1016/j.kint.2021.04.036 · doi-reference
Prediction of Major Adverse Cardiovascular Events From Retinal, Clinic al, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort Study
10.2337/dc21-1124 · doi-reference
The central role of endoplasmic reticulum stress in Parkinson’s diseas e and targeted therapeutic strategies
10.1016/j.bcp.2026.118218 · doi-reference
TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus
10.1186/s12974-019-1688-9 · doi-reference
Melatonin prevents diabetes-associated cognitive dysfunction from microglia-mediated neuroinflammation by activating autophagy via TLR4/Akt/mTOR pathway
10.1096/fj.202002247rr · doi-reference
Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles
10.1038/s41598-020-64349-x · doi-reference
Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models
10.1007/s12035-018-1195-5 · doi-reference
Insulin in the brain: there and back again
10.1016/j.pharmthera.2012.07.006 · doi-reference